ARTIVION, INC.
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
Company positioning and business
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. [3]
Background text: Wikipedia contributors, Artivion. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: AORT (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [1]
History and key events
Founding / inception date recorded in Wikidata. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [1]
Related entities and concepts
Frequently asked questions
When was ARTIVION, INC. founded?
Founded: 1984. The linked source provides the background record. [2]
Where is the headquarters of ARTIVION, INC.?
Headquarters location: Kennesaw. The linked source provides the background record. [2]
Sources and review dates
- Company identity and profile data ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Artivion (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.